The resuscitation devices market size was valued at USD 8.33 billion in 2024 and is expected to reach USD 12.05 billion by 2032, growing at a CAGR of 4.74% over 2025-2032.
The resuscitation devices market has been propelled by the growing prevalence of cardiac arrest, respiratory failure, and neonatal emergencies, as well as technological breakthroughs and increasing legislative requirements. The American Heart Association reported that over 356,000 occurrences of out-of-hospital cardiac arrest happen every year in the US, while the survival rates remain abysmally low at about 10%, indicating the significance of defibrillation and CPR in addressing critical incidents.
On a global scale, about 17.9 million people die of cardiovascular diseases, adding to the market demand for resuscitation equipment, explained AHA. A study published in JAMA Cardiology and PMC points to increasing COPD-linked hospitalizations and post-COVID-19 respiratory complications are other drivers of the growing demand for resuscitation tools such as BVMs and mechanical ventilators. Moreover, increased government and institutional funding in public-access AED programs is indicated by the AHA. According to them, the number of AEDs reached about 4.5 million globally in 2023. Furthermore, recalls, such as the FDA’s Class I recall of neonatal resuscitators and Vyaire Medical’s emergency recall of BVMs, personify the focus on product safety and efficacy. Life-saving technology is also being propelled to the limits of innovation by R&D advancement, including AI models of neonatal resuscitation devices published in Scientific Reports in 2025, and NIH’s next-generation defibrillation devices.
Drivers:
Rising Demand and Technological Advancements Fuel Growth
The resuscitation devices market is largely driven by the rising incidence of life-threatening medical emergencies such as cardiac arrests and respiratory failures. More than 60,000 cardiac events occur in UK hospitals every year, and patients’ chances of surviving are “heavily reliant” on intervention, according to the Resuscitation Council UK. The American Heart Association states that providing CPR by bystanders can almost double or triple a patient’s chance of living, necessitating a rising requirement for automated external defibrillators and manual ones.
For instance, according to a PMC study, the rising incidence of post-pandemic respiratory troubles has redoubled the necessity for advanced ventilation technologies.
Regulatory support, such as the FDA’s 2023 AED usability improvement recommendations, has the potential to inspire novel innovations, while NIH-backed research is focused on next-generation resuscitation inventions like AI-facilitated CPR devices. Additionally, progress in public health infrastructure investment, such as a nationwide AED registry in Germany, stimulates development. Private R&D investment seems to be growing, with businesses such as Stryker and Medtronic developing portable AI-integrated resuscitation kits to enhance the efficiency of emergency response.
Restraints:
High Costs and Regulatory Hurdles Limit Adoption
Nevertheless, the resuscitation devices market is challenged by factors such as high device prices and strict regulatory demands. While the cost of some advanced AEDs with real-time feedback can exceed USD 2,000 per unit and is not affordable for many low-income settings, some BVMs have lately been recalled by the FDA due to quality issues. It indicates that difficulties in manufacturing complicate the process of bringing new solutions to the market. The issue is exacerbated by poor standardization of certification procedures in the EU, particularly under MDR guidelines, which leads to lengthy market entry processes and negatively impacts the willingness of small device makers to create and sell new technology.
The lack of standardized training programs also affects the ability of end-users to deploy life-saving devices effectively. There are also market barriers created by disruptions in the supply chain, such as the one that occurred due to a silicone shortage. Growing R&D investment is balanced by a high level of failure of smart resuscitation devices in clinical trials, which creates financial risks for developers. All these factors prevent the broad adoption of new technology even in conditions of growing demand.
By Product
In terms of the product, external defibrillators accounted for 55% of the market share in 2024 due to their role in managing cardiac arrest. Automated external defibrillators are highly popular in public locations and healthcare settings thanks to various regulations, such as the EU-wide Public Access Defibrillation programs and the AHA’s recommendations on community readiness in sudden cardiac arrest. The growing use of voice-guided options and real-time CPR feedback also contributes to the product’s prevalence. The airway management device has become the fastest-growing segment, with an 18% growth rate annually. As a result, COPD and post-COVID emergencies requiring respiratory assistance are driving the product’s adoption. Video laryngoscopes and disposable bag-valve masks are the most common innovative approaches to ensure responsibility among paramedics and emergency physicians in pre-hospital and intensive care settings.
By Patient Type
Adult patients held 70% of the overall market size, as cardiac arrests and respiratory failures are more common in this age group. According to AHA data, 90% of such arrests occur in those over 40, and an aging population and increasing instances of heart disease continue to fuel demand. On the other hand, pediatric patients are the fastest-growing at 12% annual growth due to rising concentration on neonatal resuscitation and complications arising from preterm birth. T-piece resuscitators and carbon dioxide detectors are becoming increasingly used in the NICU, bolstered by revised Neobattlefield resuscitation protocols (NRP).
By End User
The hospitals & cardiac centers segment was the largest, with a 60% market share in 2024, dominated by high-volume emergency cases and critical care requirements. Moreover, it has wide-ranging resuscitation capacities, incorporating cutting-edge life support systems, rendering it a superior end-user. Nevertheless, the Prehospital Care Settings segment experiences the most rapid increment by 22% every year, supported by the broadening and strengthening of EMS systems and neighborhood AED projects. Additionally, the segment is propelled by paramedics and first responders because of small, mobile resuscitation apparatuses, including lightweight defibrillators, airway kits, and so forth.
In 2024, North America led the resuscitation devices market on account of advanced healthcare infrastructure, high incidence of cardiac arrest, and a large number of leading medical device manufacturers. North America accounted for approximately 42.1% of the global market share.
The U.S. resuscitation devices market size was valued at USD 2.65 billion in 2024 and is expected to reach USD 3.57 billion by 2032, growing at a CAGR of 3.86% over 2025-2032. The U.S. accounted for over 85.0% of North America’s market share owing to a high number of emergency medical procedures, public access to AEDs, and government-sponsored CPR and resuscitation programs. Canada also makes a significant contribution from nationwide EMS upgrades and training programs. Mexico is recording steady growth due to the increasing quality of emergency services and rising investment in hospital infrastructure. The U.S. is the fastest-growing country due to rising awareness of sudden cardiac arrests and a high rate of adoption of advanced airway management.
Europe is the second-largest stakeholder in the world share in the resuscitation devices market, supported by extensive public access to health services, high requirements for patient safety, and well-developed emergency medicine and resuscitation. The region contributed approximately 27.6% to the world share in 2024. Germany is the leading nation, holding about 24% due to the high number of surgical operations and the size of the medical sector investments. France and the UK are well-established players, conducting nationwide cardiac arrest promotion events and placing many AEDs nationwide. Poland is the fastest-growing country in the region due to the adoption of public-private cooperation in health care and investment in emergency response. The rest of Europe is a slow adopter, but it specifically applies to Eastern Europe, where EU money is diverted for healthcare development.
Asia Pacific is the fastest-growing regional market for resuscitation devices, supported by growing healthcare infrastructures, increased medical tourism, and rising cases of cardiovascular disorders. The region is anticipated to record the highest growth rate from 2025 to 2032, courtesy of large population sizes and advanced emergency response systems. China leads the region with a 36.2% market share while dominating urban hospital networks and strong government EMT investments. India follows China’s lead with increasing numbers of cardiac centers and public-private partnerships responsible for resuscitation training. Japan has also reported widespread resuscitation devices owing to its aging population and tech-backed healthcare systems. South Korea and Singapore are quickly emerging as portable resuscitation equipment hubs, supporting stiff competition within the region.
The resuscitation devices market features key players including Asahi Kasei Corporation, Cardinal Health, Ambu A/S, ICU Medical, Teleflex Incorporated, Drägerwerk AG, Stryker Corporation, Koninklijke Philips N.V., Nihon Kohden Corporation, Vyaire Medical, Medtronic plc, ZOLL Medical Corporation, Smiths Medical, GE Healthcare, and ResMed Inc., driving innovation in life-saving medical technologies.
In March 2024, Philips introduced its latest automated external defibrillator (AED) with AI-powered real-time CPR guidance and enhanced durability for public spaces, featuring adaptive algorithms that improve compression accuracy by 15% compared to previous models.
In November 2023, Dräger's new E-Vent emergency ventilator received 510(k) clearance, offering auto-adjusting PEEP controls and Bluetooth-enabled vital sign monitoring specifically designed for EMS and ICU resuscitation scenarios.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 8.33 billion |
| Market Size by 2032 | USD 12.05 billion |
| CAGR | CAGR of 4.74% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Airway Management Devices (Ventilators, Endotracheal Tubes, Resuscitators, Tracheostomy Tubes, Laryngeal Mask Airways, Laryngoscopes, Nasopharyngeal Airways, and Oropharyngeal Airways), External Defibrillators (Semi-automated External Defibrillators, Fully Automated External Defibrillators, Wearable Cardioverter Defibrillators), Convective Warming Blankets, and Other Resuscitation Devices) • By Patient Type (Adult Patients, Pediatric Patients) • By End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Centers, Pre-hospital Care Settings, and Other End Users) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Asahi Kasei Corporation, Cardinal Health, Ambu A/S, ICU Medical, Teleflex Incorporated, Drägerwerk AG, Stryker Corporation, Koninklijke Philips N.V., Nihon Kohden Corporation, Vyaire Medical, Medtronic plc, ZOLL Medical Corporation, Smiths Medical, GE Healthcare, and ResMed Inc. |
Ans: The Resuscitation Devices Market is projected to grow at a CAGR of 4.74% during the forecast period.
Ans: By 2032, the Resuscitation Devices Market is expected to reach USD 12.05 billion, up from USD 8.33 billion in 2024.
Ans: The resuscitation devices market is largely driven by the rising incidence of life-threatening medical emergencies such as cardiac arrests and respiratory failures.
Ans: The market for resuscitation devices is challenged by factors such as high device prices and strict regulatory demands.
Ans: North America is the dominant region in the Resuscitation Devices market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Conditions Requiring Resuscitation (2024)
5.2 Resuscitation Device Prescription Trends (2024), by Region
5.3 Healthcare Spending on Resuscitation, by Region and Payer (2024)
5.4 Emerging Trends in Resuscitation Technology (2024–2032)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Resuscitation Devices Market Segmentation by Product
7.1 Chapter Overview
7.2 Airway Management Devices
7.2.1 Airway Management Devices Market Trends Analysis (2021-2032)
7.2.2 Airway Management Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Ventilators
7.2.3.1 Ventilators Market Trends Analysis (2021-2032)
7.2.3.2 Ventilators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Endotracheal Tubes
7.2.4.1 Endotracheal Tubes Market Trends Analysis (2021-2032)
7.2.4.2 Endotracheal Tubes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Resuscitators
7.2.5.1 Resuscitators Market Trends Analysis (2021-2032)
7.2.5.2 Resuscitators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Tracheostomy Tubes
7.2.6.1 Tracheostomy Tubes Market Trends Analysis (2021-2032)
7.2.6.2 Tracheostomy Tubes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.7 Laryngeal Mask Airways
7.2.7.1 Laryngeal Mask Airways Market Trends Analysis (2021-2032)
7.2.7.2 Laryngeal Mask Airways Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.8 Laryngoscopes
7.2.8.1 Laryngoscopes Market Trends Analysis (2021-2032)
7.2.8.2 Laryngoscopes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.9 Nasopharyngeal Airways
7.2.9.1 Nasopharyngeal Airways Market Trends Analysis (2021-2032)
7.2.9.2 Nasopharyngeal Airways Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.10 Oropharyngeal Airways
7.2.10.1 Oropharyngeal Airways Market Trends Analysis (2021-2032)
7.2.10.2 Oropharyngeal Airways Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 External Defibrillators
7.3.1 External Defibrillators Market Trends Analysis (2021-2032)
7.3.2 External Defibrillators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Semi-automated External Defibrillators
7.3.3.1 Semi-automated External Defibrillators Market Trends Analysis (2021-2032)
7.3.3.2 Semi-automated External Defibrillators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Fully Automated External Defibrillators
7.3.4.1 Fully Automated External Defibrillators Market Trends Analysis (2021-2032)
7.3.4.2 Fully Automated External Defibrillators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Wearable Cardioverter Defibrillators
7.3.5.1 Wearable Cardioverter Defibrillators Market Trends Analysis (2021-2032)
7.3.5.2 Wearable Cardioverter Defibrillators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Convective Warming Blankets
7.4.1 Convective Warming Blankets Market Trends Analysis (2021-2032)
7.4.2 Convective Warming Blankets Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Other Resuscitation Devices
7.5.1 Other Resuscitation Devices Market Trends Analysis (2021-2032)
7.5.2 Other Resuscitation Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Resuscitation Devices Market Segmentation By Patient Type
8.1 Chapter Overview
8.2 Adult Patients
8.2.1 Adult Patients Market Trend Analysis (2021-2032)
8.2.2 Adult Patients Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Pediatric Patients
8.3.1 Pediatric Patients Market Trends Analysis (2021-2032)
8.3.2 Pediatric Patients Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Resuscitation Devices Market Segmentation By End User
9.1 Chapter Overview
9.2 Hospitals, Ambulatory Surgical Centers, and Cardiac Centers
9.2.1 Hospitals, Ambulatory Surgical Centers, and Cardiac Centers Market Trends Analysis (2021-2032)
9.2.2 Hospitals, Ambulatory Surgical Centers, and Cardiac Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Pre-hospital Care Settings
9.3.1 Pre-hospital Care Settings Market Trends Analysis (2021-2032)
9.3.2 Pre-hospital Care Settings Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Other End Users
9.4.1 Other End Users Market Trends Analysis (2021-2032)
9.4.2 Other End Users Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Resuscitation Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.2.3 North America Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.2.4 North America Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.2.5 North America Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.2.6.2 USA Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.2.6.3 USA Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.2.7.2 Canada Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.2.7.3 Canada Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.2.8.2 Mexico Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.2.8.3 Mexico Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3 Europe
10.3.1 Trends Analysis
10.3.2 Europe Resuscitation Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.3 Europe Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.4 Europe Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.3.5 Europe Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.6 Germany
10.3.1.6.1 Germany Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.1.6.2 Germany Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.3.1.6.3 Germany Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.7 France
10.3.7.1 France Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.7.2 France Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.3.7.3 France Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.8 UK
10.3.8.1 UK Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.8.2 UK Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.3.8.3 UK Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.9 Italy
10.3.9.1 Italy Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.9.2 Italy Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.3.9.3 Italy Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.10 Spain
10.3.10.1 Spain Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.10.2 Spain Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.3.10.3 Spain Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.12 Poland
10.3.12.1 Poland Resuscitation Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.12.1 Poland Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.12.3 Poland Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.3.12.3 Poland Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.13 Turkey
10.3.13.1 Turkey Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.13.2 Turkey Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.3.13.3 Turkey Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.14 Rest of Europe
10.3.14.1 Rest of Europe Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.14.2 Rest of Europe Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.3.14.3 Rest of Europe Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia-Pacific Resuscitation Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.4.3 Asia-Pacific Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.4 Asia-Pacific Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.4.5 Asia-Pacific Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.6.2 China Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.4.6.3 China Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.7.2 India Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.4.7.3 India Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.8.2 Japan Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.4.8.3 Japan Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.9.2 South Korea Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.4.9.3 South Korea Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.10 Singapore
10.4.10.1 Singapore Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.10.2 Singapore Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.4.10.3 Singapore Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.11 Australia
10.4.11.1 Australia Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.11.2 Australia Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.4.11.3 Australia Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.12 Rest of Asia-Pacific
10.4.12.1 Rest of Asia-Pacific Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.12.2 Rest of Asia-Pacific Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.4.12.3 Rest of Asia-Pacific Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Trends Analysis
10.5.2 Middle East and Africa East Resuscitation Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.5.3 Middle East and Africa Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.4 Middle East and Africa Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.5.5 Middle East and Africa Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.6 UAE
10.5.6.1 UAE Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.6.2 UAE Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.5.6.3 UAE Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.7 Saudi Arabia
10.5.7.1 Saudi Arabia Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.7.2 Saudi Arabia Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.5.7.3 Saudi Arabia Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.8 Qatar
10.5.8.1 Qatar Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.8.2 Qatar Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.5.8.3 Qatar Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.9 South Africa
10.5.9 1 South Africa Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.9 2 South Africa Resuscitation Devices Market Estimates and Forecasts By Patient Type (2021-2032) (USD Billion)
10.5.9 3 South Africa Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.10 Rest of Middle East & Africa
10.5.10.1 Rest of Middle East & Africa Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.10.2 Rest of Middle East & Africa Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.5.10.3 Rest of Middle East & Africa Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Resuscitation Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.6.3 Latin America Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.6.4 Latin America Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.6.5 Latin America Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.6.6.2 Brazil Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.6.6.3 Brazil Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.6.7.2 Argentina Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.6.7.3 Argentina Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America Resuscitation Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.6.8.2 Rest of Latin America Resuscitation Devices Market Estimates and Forecasts, By Patient Type (2021-2032) (USD Billion)
10.6.8.3 Rest of Latin America Resuscitation Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
12. Company Profiles
12.1 Asahi Kasei Corporation
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Cardinal Health
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Ambu A/S
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 ICU Medical
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Teleflex Incorporated
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Drägerwerk AG
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Stryker Corporation
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Koninklijke Philips N.V.
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Nihon Kohden Corporation
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Vyaire Medical
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product
Airway Management Devices
Ventilators
Endotracheal Tubes
Resuscitators
Tracheostomy Tubes
Laryngeal Mask Airways
Laryngoscopes
Nasopharyngeal Airways
Oropharyngeal Airways
External Defibrillators
Semi-automated External Defibrillators
Fully Automated External Defibrillators
Wearable Cardioverter Defibrillators
Convective Warming Blankets
Other Resuscitation Devices
By Patient Type
Adult Patients
Pediatric Patients
By End User
Hospitals, Ambulatory Surgical Centers, and Cardiac Centers
Pre-hospital Care Settings
Other End Users
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Poland
Turkey
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g., Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players